Navigation Links
Magnets in iPad2 May Alter Settings on Brain Shunt Devices: Study
Date:6/26/2012

By Maureen Salamon
HealthDay Reporter

TUESDAY, June 26 (HealthDay News) -- Magnets embedded in the Apple iPad 2 can interfere with the settings of magnetically programmable shunt valves, which are critical devices to drain excess fluid from the brains of those with hydrocephalus and other conditions, a new study suggests.

Researchers from the University of Michigan decided to investigate the phenomenon after a 4-month-old patient with hydrocephalus was found to have a shunt malfunction three weeks after getting one implanted. The baby's mother had fed the child and used the iPad simultaneously, inadvertently placing the baby's head close to the tablet computer.

"Most times, technology has helped medical care significantly. This is one case . . . where we have to be concerned about these things," said Dr. Salvatore Insinga, a neurosurgeon at the Cushing Neuroscience Institute in Manhasset, N.Y., who was not involved in the study. "We do know programmable shunts are susceptible to magnetic field fluctuations -- MRIs, for instance, can change the settings of the shunts. [But] I don't think we know all of the devices that have a magnetic influence on these things."

The study is published online June 26 in advance of the August print issue of Journal of Neurosurgery: Pediatrics.

Hydrocephaly, brain swelling caused by the build-up of cerebrospinal fluid, can occur in children and adults due to a variety of medical conditions. Medical-grade magnets are used to change the settings on programmable shunt valves that allow the passage of extra fluid to other parts of the body.

Study author Dr. Cormac Maher, a pediatric neurosurgeon at the University of Michigan, and his colleagues tested the iPad 2 with and without an Apple Smart Cover, which contains additional magnets and is the most frequently used cover for the tablet.

Exposing 10 programmable shunt valves to the iPad/cover for 10 seconds
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Magnets may help prevent rare complication of spinal anesthesia
2. Moveable Magnets Used to Forge Gastric Bypass in Pigs
3. Approval of Safer Alternative to Pradaxa Delayed by FDA
4. The Law Office of Wolf & Pravato, The Alters Firm and Morelli Ratner File Class Action Lawsuit Against Global Spray Foam Manufacturer
5. Heavy Duty Alternators and Starters Expert Elreg Distributors Ltd. Meets Needs of International Market with Launch of Spanish Website
6. Study Supports Value of Sigmoidoscopy, an Alternative to Colonoscopy
7. Molecular subtypes and genetic alterations may determine response to lung cancer therapy
8. Procedure gives patients with A-fib who cant take blood thinners alternative to reduce stroke
9. Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment
10. Brain Falters Near End of Life, but Games, Puzzles Might Slow Decline
11. Link between brain insulin resistance, neuronal stress in worsening Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Magnets in iPad2 May Alter Settings on Brain Shunt Devices: Study
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... New research ... Click here to read more on the Surviving Mesothelioma website. , ... Hospital in Missouri reviewed more than 12,000 cases of mesothelioma occurring between 1990 and ...
(Date:7/30/2015)... ... ... Bird B Gone, the leader in bird control products for commercial, industrial ... birds from the AC units and ventilation systems on hospital roofs. Bird droppings can ... Nile virus. When these droppings dry, the fine powder can be carried into hospitals ...
(Date:7/30/2015)... ... July 30, 2015 , ... Author Dr. Raul Llanos seeks to ... his new self-help book, “ Consciously Healing our Webs of Health, Wellbeing, Success, and ... “If we take responsibility for ourselves, we can create better realities.” His book illustrates ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... After conducting ... , St. John’s Episcopal Hospital in Far Rockaway, N.Y., has hired Gerard ... , With more than 25 years of healthcare leadership experience, Walsh is an expert ...
(Date:7/30/2015)... ... July 30, 2015 , ... After a three year trial ... implant, more commonly known as the “bionic eye,” researchers have determined the trial to ... tool for patients facing or already affected by complete vision loss as a result ...
Breaking Medicine News(10 mins):Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2Health News:Bird B Gone’s New Bird Hazing System Keeps Disease-Carrying Bird Droppings Out of Hospitals 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 4Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 5Health News:The Vision Enhancing “Bionic Eye” Deemed Safe For Long Term Use After Three Year Clinical Trial 2
... Diagnostics, Holding Promise for Melanoma Patients, NEW ... International Melanoma Congress signals new promise,and hope in treating ... for,those in the advanced stages. Caught early, melanoma is ... melanoma is one of the most incurable,and deadly., ...
... 25 Fire evacuation from the comfort of,your home to ... of a,stadium is difficult for anyone. But it,s harder on ... living. Senior Beth Price was overcome with confusion when ... at 2:00 am on Tuesday morning. "We,didn,t get much notice, ...
... Assist in California Fires Response Effort, TALLAHASSEE, Fla., ... to the California wildfires, the Capital Area Chapter of,the ... the effort. "Whether across the country or around ... is prepared to respond to tragedy and in this,case, ...
... The 2007 Southern California,wildfires have disrupted the lives ... tremendous impact on a person emotionally and physically,including ... have,had to evacuate immediately, leaving behind their homes, ... ever be the same. Aside to,evacuees being affected, ...
... help prevent Alzheimer disease , Alzheimer disease (AD), ... of dementia, is characterized by the formation in the ... indicates that some drugs used to treat high blood ... AD. In a new study, in which they screened ...
... air a way out, experts say , THURSDAY, ... treat emphysema patients shows promise, researchers say. , ... (COPD), is a progressive, irreversible lung disease characterized ... are limited. , The new strategy, called airway ...
Cached Medicine News:Health News:Genes Unlock New Treatments for Deadly Melanoma 2Health News:St. Paul's Senior Homes & Services Welcomes Some of San Diego's Neediest Displaced Seniors 2Health News:St. Paul's Senior Homes & Services Welcomes Some of San Diego's Neediest Displaced Seniors 3Health News:Capital Area Chapter Deploys Volunteers to California 2Health News:California Association of Marriage & Family Therapists Offers Tips on How to Cope With a Traumatic Event 2Health News:JCI table of contents: Oct. 25, 2007 2Health News:JCI table of contents: Oct. 25, 2007 3Health News:JCI table of contents: Oct. 25, 2007 4Health News:JCI table of contents: Oct. 25, 2007 5Health News:JCI table of contents: Oct. 25, 2007 6Health News:JCI table of contents: Oct. 25, 2007 7Health News:JCI table of contents: Oct. 25, 2007 8Health News:JCI table of contents: Oct. 25, 2007 9
(Date:7/30/2015)...  Medimetriks Pharmaceuticals, Inc. announced today that its ... study for Ozenoxacin, a novel bactericidal non-fluorinated quinolone ... U.S. rights to Ozenoxacin 1% cream.  ... with an emphasis on U.S. patients, involved 412 ... older with a clinical diagnosis of bullous or ...
(Date:7/30/2015)...   Gaumard® Scientific Company today announced ... first operating system to support an entire family ... Gaumard users. UNI® version 2.27.21.0 adds enhanced functionality ... as well as improvements to laboratory functions, patient ... as EtCO 2 .  First ...
(Date:7/30/2015)... -- Global ENT (Ear, Nose, And ... 23.01 million in 2022, according to a new study ... population, increasing prevalence of ear, nose, and throat related ... target customer base are expected serve this market as ... to estimates published by the WHO, 15% of adult ...
Breaking Medicine Technology:Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 2Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5
... /PRNewswire-Asia/ -- Chindex International, Inc. ("Chindex") (Nasdaq: ... of Western healthcare products and services in the ... (Group) Co., Ltd. ("Fosun Pharma"), a leading manufacturer ... devices in China, today announced the formation of ...
... 27, 2010 K-V Pharmaceutical Company (NYSE: KVa/KVb) today announced ... ended March 31, 2010 with the Securities and Exchange Commission. ... filing its delayed fiscal 2010 Form 10-K to enable its ... The Company is currently working on preparing and ...
Cached Medicine Technology:Chindex and Fosun Pharma Form Joint Venture 2Chindex and Fosun Pharma Form Joint Venture 3Chindex and Fosun Pharma Form Joint Venture 4Chindex and Fosun Pharma Form Joint Venture 5K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 2K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 3K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 4K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 5K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 6K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 7K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 8
... The Elite II features ... proven University of Glasgow,(UG) algorithm. ... criteria to age, the UG,algorithm ... clinically,significant criteria: gender, age, race, ...
... face provides three contrast levels (high, 9.5 % ... 20/100. This test is designed to detect very ... contact lens evaluation or due to refractive surgery. ... the same contrast and acuity levels as the ...
The CSV-1000ETDRS10% test face presents the standard ETDRS test at a contrast level of 10%. This test is widely used in clinical studies for the evaluation of refractive surgery and contact lenses....
The CSV-1000-1.5CPD is a special test face designed specifically for Food and Drug Administration clinical trials., ,At the recommended test distance of 8 feet, the gratings test one spatial frequenc...
Medicine Products: